1. Cotton PB. 2012; Endoscopic retrograde cholangiopancreatography: maximizing benefits and minimizing risks. Gastrointest Endosc Clin N Am. 22:587–599. DOI:
10.1016/j.giec.2012.05.002. PMID:
22748250.
2. Statements and guidelines developed by the Standards of Training and Practice Committee of the ASGE. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc. 1988; 34 Suppl 3:1S–40S. DOI:
10.1016/j.gie.2019.09.007. PMID:
31791596.
3. ASGE Standards of Practice Committee. Chandrasekhara V, Khashab MA, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017; 85:32–47. DOI:
10.1016/j.gie.2016.06.051. PMID:
27546389.
Article
4. Andriulli A, Loperfido S, Napolitano G, et al. 2007; Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 102:1781–1788. DOI:
10.1111/j.1572-0241.2007.01279.x. PMID:
17509029.
Article
5. Herreros de Tejada A, Calleja JL, Díaz G, et al. 2009; Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial. Gastrointest Endosc. 70:700–709. DOI:
10.1016/j.gie.2009.03.031. PMID:
19560764.
Article
6. Park CH, Park SW, Yang MJ, et al. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis. Surg Endosc. 2021; [Epub ahead of print]. DOI:
10.1007/s00464-021-08491-1. PMID:
34231067.
Article
7. Park CH, Jung JH, Nam E, et al. 2018; Comparative efficacy of various endoscopic techniques for the treatment of common bile duct stones: a network meta-analysis. Gastrointest Endosc. 87:43–57.e10. DOI:
10.1016/j.gie.2017.07.038. PMID:
28756105.
Article
8. Cotton PB, Lehman G, Vennes J, et al. 1991; Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 37:383–393. DOI:
10.1016/S0016-5107(91)70740-2. PMID:
2070995.
Article
11. Loperfido S, Angelini G, Benedetti G, et al. 1998; Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 48:1–10. DOI:
10.1016/S0016-5107(98)70121-X. PMID:
9684657.
Article
12. Syrén E, Eriksson S, Enochsson L, Eklund A, Sandblom G. 2019; Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography. BJS Open. 3:485–489. DOI:
10.1002/bjs5.50162. PMID:
31406957. PMCID:
PMC6681151.
Article
13. Masci E, Mariani A, Curioni S, Testoni PA. 2003; Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 35:830–834. DOI:
10.1055/s-2003-42614. PMID:
14551860.
Article
14. Chen JJ, Wang XM, Liu XQ, et al. 2014; Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years. Eur J Med Res. 19:26. DOI:
10.1186/2047-783X-19-26. PMID:
24886445. PMCID:
PMC4035895.
Article
16. Tse F, Yuan Y, Moayyedi P, Leontiadis GI. 2013; Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 45:605–618. DOI:
10.1055/s-0032-1326640. PMID:
23807804.
Article